Wegovy clinical studies and reported hair loss percentages Wegovy clinical trials show more notable results: Hair loss affected 3% of adult participants compared to 1% in the placebo group [7] The numbers were higher in children 12 and older, where 4% reported hair loss while the placebo group showed no cases [8] Comparing hair loss rates across different GLP-1 medications GLP-1 medications of all types show distinct patterns: Tirzepatide (Mounjaro): Users reported hair loss rates between 4.9% to 5.7% at doses from 5mg to 15mg [8] Zepbound: The overall rates reached 4% to 5%, with women showing much higher numbers 7.1% compared to just 0.5% in men [8] Research from the University of British Columbia shows that people who use semaglutide have a 52% higher chance of hair loss compared to those taking older weight loss medications [9]
Oral Wegovy (Semaglutide Pill) Offering an alternative to injections, oral Wegovy was approved in December 2025, providing a daily pill that simplifies weight management while delivering the same benefits of GLP-1 science
If your testosterone prefers the 5a pathway then you are likely to have more severe symptoms of PCOS like facial hair
This means you feel fuller longer after meals, which naturally reduces your overall calorie intake
Additionally, several of these parasites have the potential for transmission to humans
However, there are a number of reasons why people may stop taking these drugs
.webp?t=1743535811)
